Clinical Trial Update: SB-480848 In Subjects With Coronary Heart Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of SB-480848 in subjects with coronary heart disease has completed. No efficacy results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• SB-480848

Snippet

Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 2 | Status: COMPLETED